Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference
-
Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference
-
Pre-Open Stock Movers 03/28: (KXIN) (HYMC) (TSLA) Higher; (BYND) (VIR) (MCHP) Lower (more...)
-
Vir Biotechnology to Participate in the 42nd Annual Cowen Healthcare Conference
-
Vir Biotechnology to Participate in the 42nd Annual Cowen Healthcare Conference
-
Vir Biotechnology (VIR) Estimates Raised at Cowen on $1B U.S. Government Deal for Sotrovimab
-
Vir Biotechnology Inc. (VIR) Enters $300M Stock Sales Agreement with Cowen
-
Vir Biotechnology Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Vir Biotechnology Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Vir Biotechnology Inc. (VIR) Prices 7.14M Share Common Offering at $42/Sh
-
Vir Biotechnology Announces Pricing of Public Offering of Common Stock
-
Vir Biotechnology Announces Pricing of Public Offering of Common Stock
-
Vir Biotechnology Inc. (VIR) Announces Proposed Public Offering of Common Stock
-
Vir Biotechnology Announces Proposed Public Offering of Common Stock
-
Vir Biotechnology Announces Proposed Public Offering of Common Stock
-
Vir Biotechnology to Present at 40th Annual Cowen Healthcare Conference
-
Cowen Starts Vir Biotechnology (VIR) at Outperform
-
SoftBank-backed Vir Biotechnology's shares tumble in market debut
-
Vir Biotechnology (VIR) IPO Opens 19% Lower
-
Vir Biotechnology Inc. (VIR) Prices 7.14M Share IPO at $20/Sh
-
SoftBank-backed Vir Biotechnology raises $143 million in U.S. IPO
-
Vir Biotechnology Announces Pricing of Initial Public Offering

